Search global stocks & ETFs...Ctrl K

Learn Mode

ILMN - Illumina Inc

82

$144.62

-$0.22 (-0.148%)

5/22/26, 3:25 PM

Score

3.42/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

ILMN

Valuation Score

View as %

Stock Unlock

YTD

Max

Stock Profile

Market Cap

$21.92B

Industry

Life Sciences Tools & Services

EPS (TTM)

$5.52

P/E (TTM)

25.70

Div & Yield

FCF Payout Ratio

P/S (TTM)

4.99

P/B

8.19

Diluted Shares

154.00M

Ex-Dividend

Next Earnings

07-29

Forward P/E

26.57

Payout Ratio

P/FCF (TTM)

22.50

FCF Yield

4.44%

Earnings Yield

3.89%

52 Week Range

Score Card

Explore Scores Tab

3.42

Good

Illumina Inc has grown revenue at 1.29% over the past year, which suggests sales are increasing. Also, it has seen its diluted average shares outstanding decrease by -3.14% over the past year, which suggests the company is buying back shares.

Valuation Model

Key Score

1.00

Very Bad

Management

1.00

Very Bad

Growth

3.00

Average

Profitability

4.00

Good

Fin. Health

2.00

Bad

Dividends

Analyst

3.00

Average

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

1 new filing was in the last 7 days

Filter Form Types

Form SD

Specialized Disclosure Report

Filed on 2026-05-19 16:16:55

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-14 19:21:35

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-05-14 13:55:36

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-05-13 17:36:38

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-11 19:34:10

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-05-07 18:20:13

Form 144

Notice of proposed sale of securities pursuant to Rule 144

Filed on 2026-05-06 16:10:13

Form 10-Q

General form for quarterly financial reports under Section 13 or 15(d)

Filed on 2026-05-01 17:52:46

Form SCHEDULE 13G

Unknown Form Type

Filed on 2026-04-30 10:37:56

Form ARS

Unknown Form Type

Filed on 2026-04-09 16:21:21

Form DEFA14A

Additional definitive proxy soliciting materials

Filed on 2026-04-09 16:18:50

Form DEF 14A

Also known as a 'definitive proxy statement', is a required filing when a shareholder vote is required

Filed on 2026-04-09 16:16:45

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-05-11

High:

$183.75

27.1%

Avg:

$144.02

-0.4%

Low:

$95.95

-33.7%

(% change is relative to the current stock price: $144.62)

Analyst Recommendations

Go to Analyst Tab

3.68

Good

29%

Strong Buy (8)

25%

Buy (7)

36%

Hold (10)

Sell (2)

Strong Sell (1)

About

Website
https://www.illumina.com
Address
5200 Illumina Way, San Diego CALIFORNIA, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1110803

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company is headquartered in San Diego, California and currently employs 8,600 full-time employees. The company went IPO on 2000-06-28. The firm's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. The company also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.

IPO Date

2000-06-28

Industry

Life Sciences Tools & Services

Total Employees

8,625

Exchange

Nasdaq Nms - Global Market

Reporting Currency

USD

GICS

Life Sciences Tools & Services

GICS Sub

Life Sciences Tools & Services

GICS Sector

Health Care

GICS Group

Pharmaceuticals, Biotechnology & Life Sciences

ILMN - Illumina Inc

82

$144.62

-$0.22 (-0.148%)

3.42/5

Stock Unlock

Stock Profile

Score Card

Good

Insider Transactions

Market News

Form SD

Filed on 2026-05-19 16:16:55

Form 4

Filed on 2026-05-14 19:21:35

Form SCHEDULE 13G/A

Filed on 2026-05-14 13:55:36

Form 144

Filed on 2026-05-13 17:36:38

Form 4

Filed on 2026-05-11 19:34:10

Form 4

Filed on 2026-05-07 18:20:13

Form 144

Filed on 2026-05-06 16:10:13

Form 10-Q

Filed on 2026-05-01 17:52:46

Form SCHEDULE 13G

Filed on 2026-04-30 10:37:56

Form ARS

Filed on 2026-04-09 16:21:21

Form DEFA14A

Filed on 2026-04-09 16:18:50

Form DEF 14A

Filed on 2026-04-09 16:16:45

Financials

Price Targets

27.1%

-0.4%

-33.7%

Analyst Recommendations

About

Similar Stocks